M. Bahman, N. Sandler Topelius, T. Viitala
[ Eur. J. Pharm. Sci, 2025, 211, 107122; https://doi.org/10.1016/j.ejps.2025.107122 ]
Semi-solid extrusion (SSE) as a way of 3D printing has shown a substantial potential in personalized medicine for pediatric patients. However, manufacturing tablets through 3D printing is a slow process and might be a bottleneck when many personalized dosages are needed for pediatric use. A simplified SSE printing approach for preparing propranolol, spironolactone, and prednisolone tablets (n= 144 of each) with different dosages was considered. All formulations showed an appropriate homogeneity (AV<15) and stability up to 9 month. Dissolution results of the tablets complied with acceptance criteria (USP) for immediate release dosage forms, the osmolality of placebo, propranolol, spironolactone, and prednisolone tablets were 86, 81, 78, and 75 mOsm/kg, respectively. Drug recovery tests via nasogastric tube (NGT) were performed with different reconstitution volumes and temperatures. The drug losses varied between 4–36%.







